L'intérêt à découvert pour Marsh & McLennan donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Marsh & McLennan. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Marsh & McLennan (NYSE:MMC) Stock, Rapport sur les intérêts à découvert

Marsh & McLennan

Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Companies Inc

NYLI MacKay California Muni Intermediate ETF

Members Co Ltd

MAG MILE CAPITAL,INC by Mag Mile Capital Inc.

Mag Mile Capital Inc

Andean Silver Ltd

Mind Medicine Inc Warrants(11/12/2023)

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 3.99% on an annualized basis producing an average annual return of 15.76%. Currently, Marsh &amp; McLennan has a market capitalization of $111.68 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 15 years ago, it would be worth $9,254.28 today based on a price of $227.10 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729096273_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 15 Years

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) is set to give its latest quarterly earnings report on Thursday, 2024-10-17. Here's what investors need to know before the announcement.
Analysts estimate that Marsh &amp; McLennan will report an earnings per share (EPS) of $1.61. 
The announcement from Marsh &amp; McLennan is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 0.31% drop in the share price the next day.
Here's a look at Marsh &amp; McLennan's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.40</td>
<td>2.80</td>
<td>1.63</td>
<td>1.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.41</td>
<td>2.89</td>
<td>1.68</td>
<td>1.57</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>0.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729087359_0.png" alt="eps graph" />
<h3>Tracking Marsh &amp; McLennan's Stock Performance</h3>
Shares of Marsh &amp; McLennan were trading at $226.06 as of October 15. Over the last 52-week period, shares are up 18.7%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Opinions on Marsh &amp; McLennan</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Marsh &amp; McLennan.
Analysts have given Marsh &amp; McLennan a total of 7 ratings, with the consensus rating being Neutral. The average one-year price target is $231.29, indicating a potential 2.31% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Aon, Arthur J. Gallagher and Brown &amp; Brown, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>For Aon, analysts project an Neutral trajectory, with an average 1-year price target of $351.91, indicating a potential 55.67% upside.</li>
<li>Arthur J. Gallagher received a Neutral consensus from analysts, with an average 1-year price target of $289.4, implying a potential 28.02% upside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Brown &amp; Brown, with an average 1-year price target of $108.45, indicating a potential 52.03% downside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Aon, Arthur J. Gallagher and Brown &amp; Brown, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marsh &amp; McLennan</td>
<td>Neutral</td>
<td>5.87%</td>
<td>$2.77B</td>
<td>8.72%</td>
</tr>
<tr>
<td>Aon</td>
<td>Neutral</td>
<td>18.35%</td>
<td>$1.63B</td>
<td>18.30%</td>
</tr>
<tr>
<td>Arthur J. Gallagher</td>
<td>Neutral</td>
<td>13.66%</td>
<td>$1.12B</td>
<td>2.48%</td>
</tr>
<tr>
<td>Brown &amp; Brown</td>
<td>Neutral</td>
<td>11.39%</td>
<td>$569M</td>
<td>4.30%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Marsh &amp; McLennan ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Discovering Marsh &amp; McLennan: A Closer Look</h3>
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
<h3>Key Indicators: Marsh &amp; McLennan's Financial Health</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Marsh &amp; McLennan showcased positive performance, achieving a revenue growth rate of 5.87% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Marsh &amp; McLennan's net margin is impressive, surpassing industry averages. With a net margin of 18.08%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.72%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Marsh &amp; McLennan's ROA excels beyond industry benchmarks, reaching 2.34%. This signifies efficient management of assets and strong financial health.
Debt Management: Marsh &amp; McLennan's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.15.
<a href="https://www.benzinga.com/quote/MMC/earnings">To track all earnings releases for Marsh &amp; McLennan visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Insights Ahead: Marsh & McLennan's Quarterly Earnings

B of A Securities analyst Joshua Shanker maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $248 to $250.

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on Marsh & McLennan, Raises Price Target to $250

Wells Fargo analyst Elyse Greenspan maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight and lowers the price target from $212 to $211.

Wells Fargo Maintains Equal-Weight on Marsh & McLennan, Lowers Price Target to $211

Jefferies analyst Yaron Kinar maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Hold and raises the price target from $219 to $222.

Jefferies Maintains Hold on Marsh & McLennan, Raises Price Target to $222

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TIGR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$17.00</td>
<td>$27.5K</td>
<td>0</td>
<td>7.5K</td>
</tr>
<tr>
<td>FUTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$150.00</td>
<td>$156.0K</td>
<td>1.3K</td>
<td>5.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$22.00</td>
<td>$26.0K</td>
<td>1.9K</td>
<td>1.7K</td>
</tr>
<tr>
<td>BX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$140.00</td>
<td>$270.0K</td>
<td>1.2K</td>
<td>1.5K</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$40.00</td>
<td>$47.2K</td>
<td>5.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>HIG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$120.00</td>
<td>$28.7K</td>
<td>1.0K</td>
<td>391</td>
</tr>
<tr>
<td>MMC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$195.00</td>
<td>$242.1K</td>
<td>87</td>
<td>130</td>
</tr>
<tr>
<td>RKT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.00</td>
<td>$36.4K</td>
<td>251</td>
<td>50</td>
</tr>
<tr>
<td>NU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.00</td>
<td>$26.5K</td>
<td>4.2K</td>
<td>49</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/04/24</td>
<td>$482.50</td>
<td>$26.6K</td>
<td>10</td>
<td>22</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TIGR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>), we observe a call option sweep with bullish sentiment. It expires in 15 day(s) on October 18, 2024. Parties traded 1100 contract(s) at a $17.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $27.5K, with a price of $25.0 per contract. There were 0 open contracts at this strike prior to today, and today 7509 contract(s) were bought and sold. 
• Regarding FUTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>), we observe a call option sweep with bullish sentiment. It expires in 15 day(s) on October 18, 2024. Parties traded 306 contract(s) at a $150.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $156.0K, with a price of $510.0 per contract. There were 1339 open contracts at this strike prior to today, and today 5207 contract(s) were bought and sold. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option sweep that happens to be bullish, expiring in 1 day(s) on October 4, 2024. This event was a transfer of 466 contract(s) at a $22.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $56.0 per contract. There were 1942 open contracts at this strike prior to today, and today 1708 contract(s) were bought and sold. 
• For BX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on November 15, 2024. This event was a transfer of 900 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $270.0K, with a price of $300.0 per contract. There were 1222 open contracts at this strike prior to today, and today 1500 contract(s) were bought and sold. 
• For BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on November 15, 2024. This event was a transfer of 236 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $47.2K, with a price of $200.0 per contract. There were 5276 open contracts at this strike prior to today, and today 1123 contract(s) were bought and sold. 
• For HIG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>), we notice a call option sweep that happens to be neutral, expiring in 15 day(s) on October 18, 2024. This event was a transfer of 379 contract(s) at a $120.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $28.7K, with a price of $77.0 per contract. There were 1094 open contracts at this strike prior to today, and today 391 contract(s) were bought and sold. 
• For MMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), we notice a call option trade that happens to be bullish, expiring in 15 day(s) on October 18, 2024. This event was a transfer of 90 contract(s) at a $195.00 strike. The total cost received by the writing party (or parties) was $242.1K, with a price of $2690.0 per contract. There were 87 open contracts at this strike prior to today, and today 130 contract(s) were bought and sold. 
• Regarding RKT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), we observe a call option sweep with bullish sentiment. It expires in 834 day(s) on January 15, 2027. Parties traded 50 contract(s) at a $15.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $36.4K, with a price of $730.0 per contract. There were 251 open contracts at this strike prior to today, and today 50 contract(s) were bought and sold. 
• Regarding NU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), we observe a call option sweep with bullish sentiment. It expires in 470 day(s) on January 16, 2026. Parties traded 39 contract(s) at a $7.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $680.0 per contract. There were 4232 open contracts at this strike prior to today, and today 49 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a call option trade with neutral sentiment. It expires in 1 day(s) on October 4, 2024. Parties traded 22 contract(s) at a $482.50 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $1213.0 per contract. There were 10 open contracts at this strike prior to today, and today 22 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

FUTU

HOOD

TIGR

10 Financials Stocks Whale Activity In Today's Session

B of A Securities analyst Joshua Shanker maintains Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Neutral and raises the price target from $235 to $248.

B of A Securities Maintains Neutral on Marsh & McLennan, Raises Price Target to $248

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.marshmclennan.com&amp;esheet=54128665&amp;newsitemid=20240930309858&amp;lan=en-US&amp;anchor=Marsh+McLennan&amp;index=1&amp;md5=63108aa7cc979825dd4a7df9434061de">Marsh McLennan</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), a global leader in risk, strategy and people, today announced that it has reached an agreement through its Marsh McLennan Agency business to acquire McGriff Insurance Services, LLC, an affiliate of TIH. McGriff is a leading provider of insurance broking and risk management services in the United States, with $1.3 billion of revenue for the trailing twelve months ended June 30, 2024. The transaction will enhance Marsh McLennan Agency's capabilities across commercial property and casualty, employee benefits, management liability and personal lines.
Under the terms of the transaction, Marsh McLennan will pay $7.75 billion in cash consideration, funded by a combination of cash and proceeds from debt financing. In conjunction with the transaction, Marsh McLennan will assume a deferred tax asset valued at approximately $500 million. The transaction is targeted to close by year-end, subject to regulatory clearance and other standard closing conditions.

Marsh McLennan To Snap McGriff Insurance Services For $7.75B

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 3.51% on an annualized basis producing an average annual return of 17.79%. Currently, Marsh &amp; McLennan has a market capitalization of $109.93 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 5 years ago, it would be worth $2,227.99 today based on a price of $223.55 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727274619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,200 Today

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/13/24</td>
<td>$19.50</td>
<td>$43.5K</td>
<td>747</td>
<td>6.5K</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$7.50</td>
<td>$65.0K</td>
<td>5.5K</td>
<td>6.0K</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$75.00</td>
<td>$153.7K</td>
<td>9.1K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MMC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$210.00</td>
<td>$270.0K</td>
<td>286</td>
<td>1.0K</td>
</tr>
<tr>
<td>USB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/13/24</td>
<td>$45.00</td>
<td>$41.1K</td>
<td>208</td>
<td>967</td>
</tr>
<tr>
<td>KKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$120.00</td>
<td>$104.4K</td>
<td>49</td>
<td>500</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$65.00</td>
<td>$67.5K</td>
<td>227</td>
<td>224</td>
</tr>
<tr>
<td>COIN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$180.00</td>
<td>$533.0K</td>
<td>2.1K</td>
<td>217</td>
</tr>
<tr>
<td>CFG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$42.50</td>
<td>$31.2K</td>
<td>818</td>
<td>200</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$40.00</td>
<td>$25.2K</td>
<td>1.4K</td>
<td>176</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option sweep that happens to be bullish, expiring in 8 day(s) on September 13, 2024. This event was a transfer of 926 contract(s) at a $19.50 strike. This particular call needed to be split into 91 different trades to become filled. The total cost received by the writing party (or parties) was $43.5K, with a price of $47.0 per contract. There were 747 open contracts at this strike prior to today, and today 6525 contract(s) were bought and sold. 
• Regarding SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we observe a put option sweep with bullish sentiment. It expires in 15 day(s) on September 20, 2024. Parties traded 1627 contract(s) at a $7.50 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $65.0K, with a price of $40.0 per contract. There were 5571 open contracts at this strike prior to today, and today 6090 contract(s) were bought and sold. 
• For PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we notice a call option trade that happens to be bearish, expiring in 43 day(s) on October 18, 2024. This event was a transfer of 750 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $153.7K, with a price of $205.0 per contract. There were 9197 open contracts at this strike prior to today, and today 1284 contract(s) were bought and sold. 
• For MMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>), we notice a put option trade that happens to be bullish, expiring in 106 day(s) on December 20, 2024. This event was a transfer of 1000 contract(s) at a $210.00 strike. The total cost received by the writing party (or parties) was $270.0K, with a price of $270.0 per contract. There were 286 open contracts at this strike prior to today, and today 1003 contract(s) were bought and sold. 
• For USB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>), we notice a put option sweep that happens to be bearish, expiring in 8 day(s) on September 13, 2024. This event was a transfer of 698 contract(s) at a $45.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $41.1K, with a price of $59.0 per contract. There were 208 open contracts at this strike prior to today, and today 967 contract(s) were bought and sold. 
• For KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), we notice a call option sweep that happens to be bullish, expiring in 197 day(s) on March 21, 2025. This event was a transfer of 90 contract(s) at a $120.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $104.4K, with a price of $1160.0 per contract. There were 49 open contracts at this strike prior to today, and today 500 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a call option trade that happens to be bullish, expiring in 498 day(s) on January 16, 2026. This event was a transfer of 90 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $67.5K, with a price of $750.0 per contract. There were 227 open contracts at this strike prior to today, and today 224 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a put option trade that happens to be bullish, expiring in 43 day(s) on October 18, 2024. This event was a transfer of 200 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $533.0K, with a price of $2665.0 per contract. There were 2182 open contracts at this strike prior to today, and today 217 contract(s) were bought and sold. 
• Regarding CFG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>), we observe a put option sweep with bearish sentiment. It expires in 43 day(s) on October 18, 2024. Parties traded 136 contract(s) at a $42.50 strike. This particular put needed to be split into 33 different trades to become filled. The total cost received by the writing party (or parties) was $31.2K, with a price of $230.0 per contract. There were 818 open contracts at this strike prior to today, and today 200 contract(s) were bought and sold. 
• For UPST (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>), we notice a call option trade that happens to be bearish, expiring in 106 day(s) on December 20, 2024. This event was a transfer of 50 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $25.2K, with a price of $504.0 per contract. There were 1447 open contracts at this strike prior to today, and today 176 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFRM

COIN

PYPL

SOFI

UPST

Barclays analyst Alex Scott initiates coverage on Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Equal-Weight rating and announces Price Target of $236.

Initiation

Barclays Initiates Coverage On Marsh & McLennan with Equal-Weight Rating, Announces Price Target of $236

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 5 years by 5.45% on an annualized basis producing an average annual return of 18.55%. Currently, Marsh &amp; McLennan has a market capitalization of $112.63 billion. 
Buying $100 In MMC: If an investor had bought $100 of MMC stock 5 years ago, it would be worth $229.97 today based on a price of $229.03 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725471011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 4.26% on an annualized basis producing an average annual return of 16.47%. Currently, Marsh &amp; McLennan has a market capitalization of $111.29 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 15 years ago, it would be worth $9,840.00 today based on a price of $226.32 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724790613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,800 Today

Shares of&nbsp;Employers Holdings, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eig#NYSE">EIG</a>) have declined 5.8% since it reported second-quarter 2024 results on Jul 31, after the closing bell. The better-than-expected earnings were aided by growth in premiums written, policies in force and higher yields on fixed maturity securities. However, the positives were partially offset by increased overall expenses.
EIG reported second-quarter adjusted earnings per share of $1.10, which surpassed the Zacks Consensus Estimate by 1.9%. However, the bottom line fell 6% year over year.
Total revenues grew 0.8% year over year to $217 million. But the top line missed the consensus mark by 3%.
<div class="chart_embed">
<h3>Employers Holdings Inc Price, Consensus and EPS Surprise</h3>
<img alt="Employers Holdings Inc Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/a7/1723643799.png" style="border-style:solid; border-width:1px; height:310px; width:600px" title="" />
Employers Holdings Inc price-consensus-eps-surprise-chart | Employers Holdings Inc Quote
</div>
<h3>Q2 Key Updates</h3>
Gross premiums written of $207.9 million advanced 5% year over year in the quarter under review on the back of new business growth and higher renewal rates, partly offset by decreased final audit premiums. Net premiums written of $206.1 million increased 5% year over year.
Net premiums earned by Employers Holdings amounted to $187.8 million, which improved 6% year over year but lagged the Zacks Consensus Estimate by 4.6%.
Net investment income climbed 0.4% year over year to $26.9 million in the second quarter due to increased yields on fixed-maturity securities. However, the decline in invested balances of fixed-maturity securities partially offset the growth. As such, the metric missed the consensus mark by only 0.1%.
Total expenses of $177 million inched up 3.3% year over year. Losses and loss adjustment expenses recorded a 20% year-over-year rise due to growth in earned premiums and increased current accident year loss and loss adjustment expense ratio. Commission expenses grew 14% year over year.
EIG reported a pre-tax income of $40 million in the quarter under review, which fell 8.7% year over year.
Policies in force were at a record level of 128,522, which increased 3% year over year.
The combined ratio increased 380 basis points (bps) year over year to 94.2% but came lower than the Zacks Consensus Estimate of 95.5%. Underwriting and general and administrative expense ratio improved 400 bps year over year to 22%.
<h3>Financial Update (as of Jun 30, 2024)</h3>
Employers Holdings exited the second quarter with investments, cash and cash equivalents of $2.47 billion, which fell from the 2023-end level of $2.5 billion.
Total assets of $3.6 billion remained flat from 2023 end.
Total stockholders&#39; equity improved from the 2023-end level of $1.01 billion to $1.02 billion.
Adjusted book value per share was $48.89, which rose from $45.41 a year ago.
<h3>Capital Deployment Update</h3>
Employers Holdings bought back shares worth $19.2 million in the second quarter. It had a leftover capacity of $44.4 million under its repurchase authorization as of Jul 31, 2024.
Management announced a quarterly&nbsp;dividend of 30 cents for the third quarter, which will be paid on Aug 28, 2024, to shareholders as of Aug 14.
<h3>Zacks Rank &amp; Key Picks</h3>
EIG currently carries a Zacks Rank #3 (Hold).
Investors interested in the broader&nbsp;Finance space may look at some better-ranked players like Aflac Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/afl#NYSE">AFL</a>), Brown &amp; Brown, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Marsh &amp; McLennan Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>), each carrying a Zacks Rank #2 (Buy) at present.
The Zacks Consensus Estimate for Aflac&#39;s current-year earnings is pegged at $6.73 per share, which indicates 8% year-over-year growth. It witnessed seven upward estimate revisions in the past 30 days against no downward movements. AFL beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 8.2%.
The Zacks Consensus Estimate for Brown &amp; Brown&#39;s 2024 earnings indicates 30.6% year-over-year growth. During the past month, BRO has witnessed five upward estimate revisions against none in the opposite direction. It beat earnings estimates in each of the past four quarters, with an average surprise of 9.8%.
The Zacks Consensus Estimate for Marsh &amp; McLennan&#39;s current-year earnings suggests a 9.4% year-over-year jump. During the past month, MMC has witnessed seven upward estimate revisions against none in the opposite direction. The consensus mark for current-year revenues indicates 6.7% growth from a year ago.
<a href="https://www.zacks.com/stock/news/2322186/employers-holdings-eig-drops-5-8-despite-q2-earnings-beat?cid=CS-BENZ-FT-analyst_blog|earnings_article-2322186">To read this article on Zacks.com click here.</a>

Earnings Beats

Large Cap

Dividends

Small Cap

Management

Markets

Employers Holdings Drops 5.8% Despite Q2 Earnings Beat

Marsh &amp; McLennan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) has outperformed the market over the past 15 years by 4.25% on an annualized basis producing an average annual return of 16.18%. Currently, Marsh &amp; McLennan has a market capitalization of $107.89 billion. 
Buying $1000 In MMC: If an investor had bought $1000 of MMC stock 15 years ago, it would be worth $9,372.50 today based on a price of $219.39 for MMC at the time of writing.
<h3>Marsh &amp; McLennan's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723226427_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,400 Today

AMERISAFE, Inc.&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio. An elevated operating expense level, resulting from an increase in loss and loss adjustment expenses incurred, underwriting and other operating costs and policyholder dividends, also contributed to the downside. Improved audit premiums partially offset the negatives.
AMSF reported second-quarter adjusted earnings per share of 58 cents, which missed the Zacks Consensus Estimate by 4.9%. Moreover, the bottom line dipped 20.5% year over year.
Operating revenues improved 3.4% year over year to $76 million. The top line beat the consensus mark by 2.4%.
<div class="chart_embed">
<h3>AMERISAFE, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="AMERISAFE, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/32/1722871229.png" style="height:265px; width:620px" title="" />
AMERISAFE, Inc. price-consensus-eps-surprise-chart | AMERISAFE, Inc. Quote
</div>
<h3>Q2 Performance</h3>
Net premiums earned of $68.6 million improved 4.6% year over year in the quarter under review and outpaced the Zacks Consensus Estimate of $66 million. The metric benefited from improved contributions from payroll audits and related premium adjustments as a result of persistent payroll strength.
Net investment income dipped 3.6% year over year to $7.4 million due to a reduced portfolio size. However, this was partially offset by improved reinvestment rates. The metric fell short of the consensus mark of $7.8 million. Fee and other losses were $75 million.
AMERISAFE reported a pre-tax underwriting profit of $6.5 million, which declined 31.2% year over year.
Total expenses escalated 10.7% year over year to $62.1 million in the second quarter.
Operating net income of $11.1 million decreased 20.2% year over year.
The net combined ratio deteriorated 510 basis points (bps) year over year to 90.5% and came higher than the consensus mark of 90%. The metric suffered due to a deteriorating net loss ratio.
<h3>Financial Update (as of Jun 30, 2024)</h3>
AMERISAFE exited the second quarter with cash and cash equivalents of $30.6 million, which declined 20.9% from the 2023-end level.
Total assets of $1.2 billion increased 0.4% from the figure in 2023-end.
Shareholders&#39; equity of $301 million grew 2.9% from the 2023-end level.
Book value per share was $15.78 as of Jun 30, 2024, which improved 3.3% from the 2023-end figure.
Return on average equity deteriorated 400 bps year over year to 14.6% in the quarter under review.
<h3>Dividend Update</h3>
Management announced a quarterly cash dividend of 37 cents per share, which will be paid out on Sep 20, 2024, to its shareholders of record as of Sep 6.
<h3>Zacks Rank</h3>
AMERISAFE currently carries a Zacks Rank #4 (Sell).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2316354/amerisafe-amsf-stock-down-5-3-since-q2-earnings-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2316354">To read this article on Zacks.com click here.</a>

Earnings Misses

AMSF

KNSL

AMERISAFE Stock Down 5.3% Since Q2 Earnings Miss

Each week,&nbsp;Benzinga&#8217;s Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here's a look at the Benzinga Stock Whisper Index for the week of August 2:
Read Also: <a href="https://www.benzinga.com/top-stories/24/08/40119459/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-july-2024-where-do-tesla-nvidia-apple-crow">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?</a>
Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): The healthcare company saw strong interest from readers during the week, which may coincide with recent <a href="https://www.gilead.com/news-and-press/press-room/press-releases/2024/7/gilead-presents-research-data-across-its-broad-and-innovative-hiv-treatment-portfolio-and-pipeline">updates </a>on its HIV treatment pipeline. The company shared new five-year clinical data for Biktarvy at the 25th International AIDS Conference. 
Gilead also highlighted safety results of Lenacapavir for HIV Prevention. Lenacapavir could be the first and only twice-yearly PrEP treatment. Gilead is set to report second-quarter financial results on Aug. 8, which could see the stock getting strong attention in the next trading week. Raymond James <a href="https://www.benzinga.com/quote/GILD/analyst-ratings">upgraded shares </a>from Market Perform to Outperform in early July.
Gilead shares are down around 0.9% over the last week, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="510" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96.png" alt="" class="wp-image-473465" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104005/Screenshot-96-768x391.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
QuantumScape (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>): The battery technology company saw shares decline after reporting second-quarter results. The stock saw a large increase in search interest from Benzinga readers. 
QuantumScape missed earnings per share estimates. An <a href="https://www.benzinga.com/news/earnings/24/07/39944935/quantumscape-stock-falls-on-q2-results-heres-why">update on liquidity</a> could be something for investors to watch as the company works to develop solid-state batteries. QuantumScape ended the quarter with $938 million in liquidity and said a recent licensing deal with PowerCo extends its cash runway into 2028, which could alleviate future financing concerns. 
QuantumScape was on the Stock Whisper Index<a href="https://www.benzinga.com/general/biotech/24/07/39752236/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet"> back in July</a> as shares surged from the announced agreement with PowerCo, which is a unit of Volkswagen Group. As part of the agreement, QuantumScape will receive royalty payments. The deal is non-exclusive, which could open QuantumScape up to make additional licensing deals in the future.
QuantumScape shares were down 17% on the week, as seen in the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97.png" alt="" class="wp-image-473473" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97-300x146.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104154/Screenshot-97-768x374.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Marsh &amp; McLennan Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>): The professional services company saw increased interest from investors. The company announced its completion of the acquisition of The Horton Group, which expands its operations and increases its presence in Indiana, Illinois, Michigan, Minnesota, Wisconsin and Florida. 
The company beat earnings per share estimates from analysts in the second quarter, while missing revenue estimates. The closing of the acquisition will be something to watch in future quarters, along with updates on how its AI-powered solutions are performing with clients.
The stock was up 4.4% over the last week, as seen on the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1">Benzinga Pro chart </a>below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="498" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98.png" alt="" class="wp-image-473477" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104213/Screenshot-98-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>): The semiconductor stock has consistently qualified for inclusion in the Stock Whisper Index for several weeks, reflecting its significant increase in investor interest. However, semiconductor stocks experienced a decline during the recent trading week. While many of the stocks in the sector are up year-to-date, ON shares are down 17% year-to-date. The company <a href="https://www.benzinga.com/news/earnings/24/07/40010835/on-semiconductor-q2-earnings-revenue-and-eps-beat-ceo-highlights-automotive-gains-strong-q3-outlook">beat analysts' estimates </a>for earnings per share and revenue in the recently reported second quarter.
Several analysts<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/40043794/on-semiconductor-manages-profitability-against-odds-5-analysts-raise-forecasts-as-i"> raised their price targets</a> on the stock after the earnings report with datacenter strength, product development, design wins and cost management among the positives mentioned.
The company highlighted a recent supply agreement with Volkswagen Group in the automotive sector during second-quarter results. Automotive continues to be an area of growth for many semiconductor companies and could be an area to watch when it comes to ON Semiconductor.
The stock was down 10.8% over the last week, as shown on the<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"> Benzinga Pro chart </a>below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99.png" alt="" class="wp-image-473479" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104235/Screenshot-99-768x385.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>): The retail stock is among the biggest trending stocks over the last week, based on Benzinga data. Costco recently announced a<a href="https://www.benzinga.com/news/24/07/39718791/costco-stock-is-rising-along-with-its-membership-fees-whats-going-on"> long-awaited membership fee hike.</a> The company will raise the cost of its annual membership fee by $5 or $10 depending on the plan, impacting around 52 million members. 
Analysts said the membership fee increase <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39736078/costco-hikes-membership-fees-at-long-last-analysts-caution-of-sell-the-news-event-p">could add more than</a> $370 million in revenues over the next two years. While some analysts were bullish on the increase, others pointed to it being a "sell the news" event and potentially already priced into the stock. One analyst also pointed to Costco stock underperforming after the last three membership fee hikes.  
With Costco shares down 4% over the last month and nearly flat over the last week, as seen on the chart below, investors could be looking to get back into Costco with the future revenue increase coming.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="505" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100.png" alt="" class="wp-image-473482" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/02104256/Screenshot-100-768x391.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Stay tuned for next week&#8217;s report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080124&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/07/39648895/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 5</a></li>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39752236/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 12</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/07/39866122/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">July 19</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/07/39986280/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">July 26</a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40011559/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields</a></li>
</ul>
Image: Benzinga

Equities

Exclusives

COST

GILD

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

CNO Financial Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>) reported second-quarter 2024 adjusted earnings per share of $1.05, which beat the Zacks Consensus Estimate by 45.8%. Moreover, the bottom line rose 94.4% year over year.
Total revenues increased 4.2% year over year to $1.07 billion in the second quarter. The top line beat the consensus mark by 16.4%.
The strong second-quarter results benefited from improved insurance product margin, premiums, and general account assets.&nbsp;However, the decline of the policyholder and other special-purpose portfolios partially offset the results.
<div class="chart_embed">
<h3>CNO Financial Group, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="CNO Financial Group, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/84/1722441570.png" style="height:265px; width:600px" title="" />
CNO Financial Group, Inc. price-consensus-eps-surprise-chart | CNO Financial Group, Inc. Quote
</div>
<h3>Second-Quarter Performance</h3>
Total insurance policy income of $641.5 million improved 2.1% year over year and beat the Zacks Consensus Estimate by 1.2% due to a rise in annuity, health and life insurance policy incomes.
CNO&#39;s net investment income increased 2.4% year over year to $409.1 million in the second quarter. General account assets grew 8.3% year over year to $351.7 million and beat the consensus mark by 14.1%. However, the policyholder and other special-purpose portfolios declined 37.3% year over year to $57.4 million.
Annuity collected premiums of $439.1 million increased 9.3% year over year. New annualized premiums for health and life products improved 4.3% year over year to $102.9 million. Annuity, Health and Life products accounted for 27.7%, 49.4% and 22.9%, respectively, of CNO&#39;s insurance margin.
Total benefits and expenses were $915.6 million, which declined 1.2% year over year. The decline in the metric was due to liability for future policy benefits remeasurement gain and a decline in other operating costs and expenses.
<h3>Financial Update (as of Jun 30, 2024)</h3>
CNO Financial exited the second quarter with unrestricted cash and cash equivalents of $878.8 million, which increased from the 2023-end level of $774.5 million. Total assets of $36.3 billion increased from $35.1 billion at 2023-end.
The debt-to-capital ratio was 43% at the end of the second quarter. It has no outstanding debt maturities till 2025.
Total shareholders&#39; equity jumped to $2.4 billion from $2.2 billion as of Dec 31, 2023.
Book value per diluted share increased to $36 in the second quarter from $33.94 at 2023-end. Adjusted operating return on equity came in at 11.2%, which improved from 8% a year ago.
<h3>Share Repurchase and Dividend Update</h3>
CNO Financial rewarded its shareholders with $60 million in the form of share buybacks and dividends of $17.2 million.
As of Jun 30, 2024, the company had remaining repurchase funds of $421.8 million.
<h3>2024 Guidance</h3>
<h3>New Update</h3>
CNO Financial now expects 2024 EPS in the range of $3.30-$3.50, indicating an increase of 10% from the 2023 figure of $3.09. The company expects the expense ratio to be in the range of 19%-19.2% for 2024, improving from the 2023 level of 19.4%. It expects $200-$250 million excess cash flow to the holding company.
<h3>Previous View</h3>
The company continues to anticipate the effective tax rate for 2024 to be around 23%. It is also aiming at a leverage of 25%-28% for this year.
<h3>Zacks Rank</h3>
CNO Financial currently carries a Zacks Rank #3 (Hold).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2313385/cno-financial-cno-q2-earnings-beat-estimates-24-eps-view-up?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313385">To read this article on Zacks.com click here.</a>

Guidance

CNO Financial Q2 Earnings Beat Estimates, '24 EPS View Up

Willis Towers Watson Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtw#NASDAQ">WTW</a>) delivered second-quarter 2024 adjusted earnings of $2.55 per share, which beat the Zacks Consensus Estimate by 11.8%.&nbsp; The bottom line increased 24% year over year.
The insurer&#39;s second-quarter results benefited from the strong revenue contribution from the Health, Wealth &amp; Career and Risk &amp; Broking segments, as well as expanded margin, partly offset by elevated expenses.
<div class="chart_embed">
Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise
<img alt="Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/10/1721911828.png" style="height:265px; width:591px" title="" />
Willis Towers Watson Public Limited Company price-consensus-eps-surprise-chart | Willis Towers Watson Public Limited Company Quote
</div>
<h3>Operational Update</h3>
Willis Towers posted adjusted consolidated revenues of $2.26 billion, up 5% year over year on a reported basis. Revenues increased 6% on both organic basis and constant currency basis. The top line beat the Zacks Consensus Estimate by 0.04%.
The total costs of providing services increased 1.7% year over year to $2 billion due to higher salaries and benefits, transaction and transformation and other operating expenses. The metric matched our estimate.
Adjusted operating income was $385 million, which increased 22% year over year. The figure was higher than our estimate of $343 million. Margin expanded 240 basis points (bps) to 17%.
Adjusted EBITDA was $466 million, up 13% year over year. The figure was higher than our estimate of $437.4 million. Adjusted EBITDA margin expanded 160 bps to 20.6%.
<h3>Quarterly Segment Update</h3>
Health, Wealth &amp; Career: Total revenues of $1.2 billion increased 4% year over year (4% increase on a constant currency and 5% increase on organic basis). The figure matched the Zacks Consensus Estimate as well as our estimate.
Organic revenue growth in Health was driven by increased project work in North America and strong client retention, new local appointments and the continued expansion of Global Benefits Management client portfolio in International and Europe.
Wealth businesses generated organic revenue growth from higher levels of Retirement work in North America and Europe and an increase in Investments business due to capital market improvements and growth from LifeSight solution.
Career had organic revenue growth from increased project work and product revenues in Employee Experience and Work &amp; Rewards.
The operating margin was 21.9%, which expanded 360 bps from the prior-year quarter, primarily from operating leverage and Transformation savings.
Risk &amp; Broking: Total revenues of $979 million increased 9% year over year (10% increase in constant currency as well as on an organic basis) and beat our estimate of $954 million and the Zacks Consensus Estimate $958 million.
Corporate Risk &amp; Broking had organic revenue growth, primarily driven by higher levels of new business activity, strong client retention and renewal increases across all geographies. Insurance Consulting and Technology had flat organic revenue growth in the reported quarter, primarily due to tempered demand for discretionary services.
The operating margin increased 450 bps from the prior-year quarter to 20.6%, primarily due to operating leverage from strong revenue growth in CRB, Transformation savings and interest income.
<h3>Financial Update</h3>
As of Jun 30, 2024, cash and cash equivalents was $1.2 billion, down 22% year over year.
Long-term debt increased 16.2% to $5.3 billion at quarter-end from the end of 2023.
Shareholders&#39; equity decreased 1.9% from the level on Dec 31, 2023, to $9.3 billion as of Jun 30, 2024.
Cash flow from operations was $431 million in the first half of 2024, which inched up 0.2% from the prior-year period.
Free cash flow for the first half of 2024 increased 3.1% to $361 million.
<h3>2024 Outlook</h3>
Willis Towers expects to deliver revenues of more than $9.9 billion.
The insurer projects to deliver an adjusted operating margin in the band of 23-23.5%.&nbsp;
Willis Towers expects to deliver adjusted diluted earnings per share in the range of $16-$17.
WTW expects Transformation Program annual cost savings of $450 million.
The insurer expects approximately $88 million in non-cash pension income. It expects a foreign currency headwind on adjusted earnings per share of approximately 10 cents.
<h3>Zacks Rank</h3>
Willis Towers currently carries a Zacks Rank #3 (Hold).
<h3>Performance of Some Other Insurers</h3>
Brown &amp; Brown, Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) second-quarter 2024 adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the Zacks Consensus Estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion. Our estimate for commission and fees growth was 7.2%.
Organic revenues improved 10% to $1 billion in the quarter under review. Investment income more than doubled year over year to $22 million. The Zacks Consensus Estimate for the metric was pegged at $18.6 million and our estimate was $23.2 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%. Our estimate for adjusted EBITDAC was $411.4 million.
Marsh &amp; McLennan Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>) reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year. Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.
The top line, however, fell short of the consensus mark by 1%. Total operating expenses of $4.58 billion increased 3.6% year over year but were lower than our estimate of $4.62 billion. MMC&#39;s adjusted operating income was $1.72 billion in the second quarter, which grew 11% year over year and beat our estimate of $1.68 billion. Adjusted operating margin improved 130 bps year over year to 29%.
Selective Insurance Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sigi#NASDAQ">SIGI</a>) reported second-quarter 2024 operating loss of $1.10 per share against the Zacks Consensus Estimate for earnings of $1.56. The company had reported an operating income of 99 cents per share in the prior-year quarter. Total revenues of $1.2 billion increased 15% from the year-ago quarter&#39;s figure, primarily due to higher premiums earned, net investment income and net premiums written. The top line missed the Zacks Consensus Estimate by 1.3%.
On a year-over-year basis, net premium written increased 13% to $1.22 billion. The figure matched our estimate. After-tax net investment income increased 11% year over year to $86 million. After-tax net underwriting loss was $137.2 million against the year-ago underwriting income of $1.2 million. Pre-tax catastrophe losses of $91 million were narrower than a loss of $100 million reported in the year-ago quarter. The combined ratio deteriorated 1,590 bps on a year-over-year basis to 116.1.
<a href="https://www.zacks.com/stock/news/2309154/willis-towers-wtw-q2-earnings-beat-estimates-improve-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2309154">To read this article on Zacks.com click here.</a>

SIGI

Willis Towers Q2 Earnings Beat Estimates, Improve Y/Y

Offerings

Marsh & McLennan Files For Mixed Shelf, Size Not Disclosed

Key deals this week: AT&T, Qualcomm, Crown Castle and more

Morgan Stanley analyst Bob Huang maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of $23...

Morgan Stanley Reaffirms Their Hold Rating on Marsh & Mclennan Companies (MMC)

ClearBridge Large Cap Growth Strategy Q3 2024 Commentary

Insurance brokers a safe bet against Hurricane Milton; reinsurers vulnerable - analysts

Jefferies analyst Yaron Kinar maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of $222.0...

Jefferies Reaffirms Their Hold Rating on Marsh & Mclennan Companies (MMC)

Wells Fargo analyst Elyse Greenspan maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of ...

Wells Fargo Sticks to Their Hold Rating for Marsh & Mclennan Companies (MMC)

Piper Sandler analyst Paul Newsome maintained a Hold rating on Marsh & Mclennan Companies (MMC – Research Report) today and set a price target of $...

Marsh & Mclennan Companies (MMC) Receives a Rating Update from a Top Analyst

ClearBridge Large Cap Growth ESG Strategy Q3 2024 Commentary

Marsh & McLennan Q3 2024 Earnings Preview

Hurricane Milton seen costing insurers as much as $50B - report

ACGL

ADBE

AMZN

APTV

ASML

ASMLF

CFCV

CINF

COVTY

CVVTF

EMKR

EQIX

FANG

INFR

LRGE

MSFT

NNDM

NVDA

OXBR

QCOM

SATS

SBUX

SQNS

TEAM

TRRSF

TTFNF

YLDE

Press Releases

Marsh McLennan and Zurich Urge Public-Private Action to Bridge Cyber Protection Gap and Boost Resilience

Aon and Marsh McLennan Call on (Re)insurance Industry to Aid Ukraine's Resilience

Insurance

Aon and Marsh McLennan call on (re)insurance industry to aid Ukraine's resilience

Employers Expect Third Consecutive Year of Health Benefit Cost Increases Above 5% in 2025, According to Mercer

Marsh McLennan Declares Quarterly Cash Dividend

Marsh McLennan to host third quarter earnings investor call on October 17

Fintech

New Report by WeBank and Oliver Wyman Reveals Development and Innovation Trends of Global Digital Banks

Marsh McLennan to Acquire McGriff Insurance Services

Expansion of Paid Leave Mandates Creates Compliance Complexity for Employers, Says Mercer

Mercer CFA Institute Global Pension Index 2024 Highlights Need for Retirement System Improvements Given Falling Birth Rates and Increasing Longevity

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

Fanhua Inc. - American depositary shares, each representing 20 ordinary shares

Fanhua

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Huize Holding Limited - American Depositary Shares

Huize Holding

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Marsh & McLennan

Intérêt court

Marsh & McLennan (NYSE:MMC) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL